Charles Schwab Investment Management Inc. reduced its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 12.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 770,338 shares of the real estate investment trust's stock after selling 106,501 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.65% of National Health Investors worth $56,897,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. GF Fund Management CO. LTD. acquired a new position in National Health Investors in the fourth quarter valued at $58,000. Farther Finance Advisors LLC increased its stake in National Health Investors by 5,000.0% in the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock valued at $68,000 after purchasing an additional 900 shares during the last quarter. NewEdge Advisors LLC acquired a new position in National Health Investors in the fourth quarter valued at $83,000. Jupiter Asset Management Ltd. acquired a new position in National Health Investors in the first quarter valued at $206,000. Finally, Sterling Capital Management LLC increased its stake in National Health Investors by 61.1% in the fourth quarter. Sterling Capital Management LLC now owns 3,099 shares of the real estate investment trust's stock valued at $215,000 after purchasing an additional 1,175 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Stock Up 0.8%
Shares of NYSE NHI traded up $0.6310 on Wednesday, hitting $76.7610. The company had a trading volume of 182,963 shares, compared to its average volume of 227,702. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $86.13. The business has a 50 day moving average of $71.81 and a two-hundred day moving average of $72.39. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.64 billion, a P/E ratio of 24.52, a PEG ratio of 3.74 and a beta of 0.73.
National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The company had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. During the same quarter in the prior year, the business earned $1.18 earnings per share. The company's revenue was up 6.7% compared to the same quarter last year. As a group, equities research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 annualized dividend and a dividend yield of 4.8%. National Health Investors's dividend payout ratio (DPR) is currently 115.02%.
Wall Street Analysts Forecast Growth
Several research firms recently commented on NHI. Wedbush upgraded National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. Truist Financial upped their target price on National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Finally, KeyCorp upgraded National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a research note on Thursday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, National Health Investors presently has an average rating of "Buy" and an average price target of $85.40.
View Our Latest Report on NHI
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.